☆ 4.4 Article

Use of whole genome sequencing to identify low-frequency mutations in SARS-CoV-2 patients treated with remdesivir

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Related references

Note: Only part of the references are listed.

Letter Public, Environmental & Occupational Health

Persistent infection with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a patient with untreated human immunodeficiency virus (HIV)

Alice Zhabokritsky et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Add to Collection

Article Pharmacology & Pharmacy

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

Laura Vangeel et al.

Summary: Remdesivir and its parent nucleoside, molnupiravir and its parent nucleoside, and the viral protease inhibitor nirmatrelvir have equipotent antiviral activity against the ancestral SARS-CoV2 strain and the variants of concern including Omicron.

ANTIVIRAL RESEARCH (2022)

Add to Collection

Article Pharmacology & Pharmacy

Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis

Daniele Focosi et al.

Summary: Despite massive usage, the global level of remdesivir resistance is very low during the COVID-19 pandemic.

ANTIVIRAL RESEARCH (2022)

Add to Collection

Article Medicine, General & Internal

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

Karim Ali et al.

Summary: This Canadian study explores the effectiveness of remdesivir as a treatment for COVID-19. The results show that remdesivir has a modest but significant impact on important outcomes for patients and healthcare systems, such as the need for mechanical ventilation.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2022)

Add to Collection

Article Immunology

Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020

Jonathon D. Kotwa et al.

Summary: The infrequent recovery of infectious SARS-CoV-2 virus from the environment suggests that the risk to healthcare workers from air and near-patient surfaces in acute care hospital wards is likely limited.

JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Article Medicine, General & Internal

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

R. L. Gottlieb et al.

Summary: In symptomatic, nonhospitalized high-risk Covid-19 patients, a 3-day course of remdesivir significantly reduced the risk of hospitalization or death compared to placebo, with acceptable safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Cell Biology

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

Laura J. Stevens et al.

Summary: This study identified mutations in the nonstructural protein 12 RNA-dependent RNA polymerase of the SARS-CoV-2 virus that confer resistance to the antiviral drug remdesivir. These mutations result in decreased preference for the drug as a substrate and can be transferred to other betacoronaviruses, causing replication defects and up to 38-fold resistance. The findings highlight the importance of further research to understand and prevent the emergence of remdesivir resistance mutations in clinical settings.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Immunology

Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection

Mario A. Martinez et al.

Summary: This article reports a case of successful treatment of a 5-month persistent COVID-19 infection in an immunocompromised patient with 30 consecutive days of remdesivir. Prolonged remdesivir infusion with concurrent cycle threshold monitoring might provide a potential solution for the treatment of difficult-to-treat infections.

OPEN FORUM INFECTIOUS DISEASES (2022)

Add to Collection

Article Cell Biology

Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection

Andreas Heyer et al.

Summary: The use of antiviral treatments such as remdesivir in patients with prolonged SARS-CoV2 infection may increase genomic diversity and give rise to novel major variants. This finding is significant for the treatment of hospitalized patients with severe disease and the potential preventive use of remdesivir in high-risk non-hospitalized patients.

CELL REPORTS MEDICINE (2022)

Add to Collection

Editorial Material Immunology

Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019

Martin Martinot et al.

Summary: A 76-year-old female with post-rituximab B-cell immuno-deficiency and persistent SARS-CoV-2 viremia developed a mutation in RdRP (D484Y) following treatment with remdesivir, but was successfully cured after supplementation with convalescent plasma.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Virology

Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool

Aine O'Toole et al.

Summary: The global virus genomics community has responded unprecedentedly to the SARS-CoV-2 pandemic, leading to significant advances in 'real-time' generation and sharing of genomic data. The development of new analytical methods, such as pangolin, has been necessary to handle the rapid growth in virus genome data production. Pangolin has processed nearly two million virus genomes, aiding in SARS-CoV-2 genomic epidemiology and providing researchers with valuable information about the pandemic's transmission lineages.

VIRUS EVOLUTION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

HyPhy 2.5-A Customizable Platform for Evolutionary Hypothesis Testing Using Phylogenies

Sergei L. Kosakovsky Pond et al.

MOLECULAR BIOLOGY AND EVOLUTION (2020)

Add to Collection

Article Multidisciplinary Sciences

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Wanchao Yin et al.

SCIENCE (2020)

Add to Collection

Article Virology

A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture

Jalees A. Nasir et al.

VIRUSES-BASEL (2020)

Add to Collection

Article Biochemical Research Methods

VIRULIGN: fast codon-correct alignment and annotation of viral genomes

Pieter J. K. Libin et al.

BIOINFORMATICS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Less Is More: An Adaptive Branch-Site Random Effects Model for Efficient Detection of Episodic Diversifying Selection

Martin D. Smith et al.

MOLECULAR BIOLOGY AND EVOLUTION (2015)

Add to Collection

Article Virology

Next generation sequencing of the hepatitis C virus NS5B gene reveals potential novel S282 drug resistance mutations

Hezhao Ji et al.

VIROLOGY (2015)

Add to Collection

Article Biochemical Research Methods

BEDTools: a flexible suite of utilities for comparing genomic features

Aaron R. Quinlan et al.

BIOINFORMATICS (2010)

Add to Collection

Article Biochemical Research Methods

Fast and accurate short read alignment with Burrows-Wheeler transform

Heng Li et al.

BIOINFORMATICS (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.